MiyaHealth, a Singapore-based SaaS healthtech firm, closed SGD 2.4 million ($1.78 million) Pre-Series A extension round, bringing the total funds raised to SGD 10.4 million ($7.7 million).
The extension round was led by Fondation Botnar, represented by Sagana, along with participation from existing investors ST Engineering Ventures, Elev8, and HealthXCapital.
Fondation Botnar is a philanthropic foundation based in Basel, Switzerland, that invests in and supports innovative programs and research and brings together actors from across sectors to create dialogue and partnerships.
MiyaHealth Use of Funds
The funds will be used to double down on MiyaHealth’s aggressive growth strategy as it looks to expand its artificial intelligence (AI)-driven interoperable digital healthcare solutions across Europe and Southeast Asia, starting with Poland, Indonesia, and the Philippines.
Founded in 2019, MiyaHealth is a software-as-a-service (SaaS) healthtech firm that specializes in providing AI-driven interoperable digital healthcare solutions. The company focuses on leveraging technology to enhance healthcare access, efficiency, and patient experiences. The company offers three product suites, namely MiyaPayor, MiyaPatient, and MiyaProvider, all of which leverage MiyaHealth’s AI and machine learning (ML) data capture, processing, and interoperability capabilities across the healthcare ecosystem.
Company: Miyahealth Pte. Ltd.
Raised: SGD 2.4M
Round: Pre-Series A
Funding Month: August 2023
Lead Investors: Fondation Botnar
Additional Investors: ST Engineering Ventures, Elev8, and HealthXCapital
Company Website: https://miyahealth.com/
Software Category: Healthcare Solutions